4//SEC Filing
ABALLI JOHN 4
Accession 0001843113-25-000003
CIK 0001274737other
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 5:20 PM ET
Size
5.8 KB
Accession
0001843113-25-000003
Insider Transaction Report
Form 4
EXAGEN INC.XGN
ABALLI JOHN
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-10-16$11.82/sh−31,787$375,598→ 714,427 total
Holdings
- 40,401(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The sale is mandated by the Issuer's satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
Documents
Issuer
EXAGEN INC.
CIK 0001274737
Entity typeother
Related Parties
1- filerCIK 0001843113
Filing Metadata
- Form type
- 4
- Filed
- Oct 19, 8:00 PM ET
- Accepted
- Oct 20, 5:20 PM ET
- Size
- 5.8 KB